Product Information
HYDROCORTISONE BUTY 0.1% CREAM is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $2.3630 per GM under NDC 51672407406. Its NADAC has been published 637 times since Nov 28, 2013.
FDA first approved this application on Aug 3, 2005. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/g
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672407406
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
HYDROCORTISONE BUTYRATEApproval Type
Generic (ANDA)
FDA Application
ANDA076654FDA Approved
8/3/2005
TE Code
AB1
On Market Since
8/4/2005
Pharmacological Classes
Price Statistics
The NADAC for HYDROCORTISONE BUTY 0.1% CREAM has been published 637 times since Nov 28, 2013, and over the history we have for it it has risen 98.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3630 per GM |
|---|---|
| All-time high | $3.2968 (Jul 13, 2016) |
| All-time low | $0.9908 (Apr 22, 2015) |
| 52-week high | $2.3899 |
| 52-week low | $1.9263 |
| Median price | $2.2887 |
| Average price | $2.3125 |
| Largest weekly change | +147.3% (May 20, 2015) |
| Weeks tracked | 637 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydrocortisone Butyrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocortisone Butyrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCORTISONE BUTY 0.1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCORTISONE BUTY 0.1% CREAM, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $2.3630 per GM (NDC 51672407406), effective Sep 30, 2026.
How has the price of HYDROCORTISONE BUTY 0.1% CREAM changed over time?
Over the history we have for it, the NADAC for HYDROCORTISONE BUTY 0.1% CREAM has risen 98.1%. It has been tracked across 637 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROCORTISONE BUTY 0.1% CREAM?
Since Nov 28, 2013, the NADAC for HYDROCORTISONE BUTY 0.1% CREAM has ranged from a low of $0.9908 (Apr 22, 2015) to a high of $3.2968 (Jul 13, 2016), with a median of $2.2887 per GM.
Are there cheaper alternatives to HYDROCORTISONE BUTY 0.1% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of HYDROCORTISONE BUTY 0.1% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROCORTISONE BUTY 0.1% CREAM?
HYDROCORTISONE BUTY 0.1% CREAM (NDC 51672407406) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.